Since August 26, 2023, Women’s Equality Day in the United States has marked the beginning of a special OncoDaily tradition – the 100 Influential Women in Oncology. On this day, we launched an initiative to recognize 100 inspiring women making a difference in oncology around the world, highlighting 10 remarkable women each week.
And this year, we’re continuing the journey with our 2026 list of 100 Influential Women in Oncology, showcasing the remarkable efforts made by these inspiring women across the world to improve cancer care.
There are so many incredible women in oncology whose work deserves to be seen and celebrated, and we know that one list can never include everyone. This is an ongoing initiative, and we’d love to hear your suggestions for the 100 Influential Women in Oncology in 2026 list. We’ll be sharing the nomination link soon.
We are proud to introduce the next 10 women featured in our 2026 list of 100 Influential Women in Oncology:
Jasmine Kamboj
Jasmine Kamboj, MD, FASCO, is medical oncologist with heavy focus on community oncology and Medical Director of the Cancer Care and Infusion Center at Northfield Hospital + Clinics in Minnesota. A nationally active cancer-policy advocate, she has served on ASCO’s Health Equity and Government Relations Committees, co-leads ASCO’s Communities of Practice on Policy, and serves on its International Affairs Committee. Her advocacy on issues including prior authorization and barriers to cancer care earned her the ASCO Advocate of the Year Award and recognition in ASCO’s President’s Circle.
Manette le Grange
Manette le Grange is the Executive Director of ACT 4 Children, a multi-stakeholder initiative addressing disparities in childhood cancer care in LMICs. She also led the development of POLARIS, a digital platform created in collaboration with the European Society for Paediatric Oncology (SIOPE) to support families navigating complex pediatric leukemia treatment pathways. Previously, she spent years at the global pharmaceutical company Servier, serving as Health Equity Program Director for Childhood Cancer Medicines.
Anjee Davis
Anjee Davis is Chief Executive Officer of Fight Colorectal Cancer (Fight CRC), one of the leading U.S. patient-advocacy organizations dedicated to colorectal cancer prevention, research, patient support, and policy. She joined Fight CRC in 2011 and became CEO in 2025, after years of leading its community engagement and advocacy programs. Anjee Davis founded the Research Advocacy Training & Support (RATS) program to prepare patients to contribute meaningfully to clinical research and trials. In 2026, she helped lead national advocacy urging Congress to establish dedicated federal funding for colorectal cancer research.
Caroline Chung
Caroline Chung, MD, MSc, is Vice President and Chief Data and Analytics Officer and Co-Director of the Institute for Data Science in Oncology at The University of Texas MD Anderson Cancer Center. A radiation oncologist specializing in central nervous system malignancies, she leads work applying quantitative imaging, artificial intelligence, and advanced data analysis to tumor characterization and personalized treatment. By building the systems needed to translate complex cancer data into clinically meaningful decisions, Chung is helping shape a more precise and responsible digital future for oncology. In 2026, she received the AI in Oncology Yvonne Award organized by OncoDaily.
Estela Rodriguez
Estela Rodriguez, MD, MPH, is a thoracic medical oncologist at the Sylvester Comprehensive Cancer Center, University of Miami, where she serves as Associate Director of Community Outreach for Thoracic Oncology. Her work has focused particularly on lung cancer screening, biomarker testing and lung cancer in women and never-smokers. Through education and community engagement, she has also worked to improve cancer awareness and participation in research among Hispanic and other underserved populations. She received Cancer GRACE’s 2024 Patient Educator of the Year Award for developing Spanish-language lung cancer education that helps address language barriers for patients and caregivers.
Foluke Sarimiye
Foluke Oladele Sarimiye, MD, MSc, FWACS, is a Nigerian radiation and clinical oncologist, psycho-oncologist, and Lecturer at the University of Ibadan, while practicing as a consultant at University College Hospital, Ibadan. Her work combines cancer treatment with psycho-oncology, survivorship, implementation science, and community-based cancer control, with particular attention to the psychosocial needs of patients, families, and oncology professionals. Her research has examined patient coping and communication in breast cancer as well as radiotherapy and brachytherapy delivery in Nigeria, while her community work includes awareness and screening initiatives for breast, cervical, and childhood cancers.
Minetta Liu
Minetta Liu, MD is a medical oncologist and Chief Medical Officer for Oncology and Early Cancer Detection at Natera, where she leads the clinical and scientific strategy for bringing circulating tumor DNA (ctDNA) and molecular residual disease testing into routine cancer care. Previously Professor of Oncology and Chair of Research in the Department of Oncology at Mayo Clinic, Liu has been a leading investigator in liquid biopsy, breast cancer biomarkers, and precision oncology, including national leadership in circulating biomarker research through the Alliance for Clinical Trials in Oncology.
Maria Nomikou
Maria Nomikou is Director of the Hellenic Cancer Federation (ELLOK), Greece’s umbrella organization for cancer patient associations, where she works across cancer policy, research, patient advocacy, and equitable access to high-quality care. Under her leadership, ELLOK became Greece’s National Cancer Mission Hub within the EU Mission on Cancer, creating a platform that connects patients, researchers, policymakers, healthcare professionals, and civil society around national cancer priorities. With more than two decades of experience in the nonprofit sector, Nomikou also contributes to European cancer research projects, including work on patient involvement and cancer genomics literacy.
Amanda Pullinger
Amanda Pullinger is the Chief Executive Officer of Debbie’s Dream Foundation: Curing Stomach Cancer, where she leads efforts to increase awareness, support patients, and accelerate research into a cancer that remains comparatively underfunded. Bringing more than two decades of international nonprofit leadership to the role, she is strengthening collaboration among patients, advocates, researchers, clinicians, and supporters across countries. Previously, Pullinger spent two decades leading 100 Women in Finance, growing it into a global network of more than 35,000 members, bringing extensive experience in international nonprofit leadership and women’s advancement to cancer advocacy.
Katie Dain
Katie Dain is the CEO of the NCD Alliance, a global civil-society network working to strengthen prevention and care for cancer and other noncommunicable diseases worldwide. She has helped place NCDs firmly on the UN and WHO global health agenda, advocating for stronger health systems, universal health coverage, sustainable financing, and equitable access to essential medicines. Dain also co-chairs the WHO Civil Society Working Group on NCDs and has served on several WHO and Lancet high-level commissions, making her an influential voice in global policies affecting cancer prevention, treatment, and health equity.
Watch on OncoDaily TV: Empowering Oncologists with Jasmine Kamboj.
More from OncoDaily 100:
